Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$0.0050
0.00%
(0.00) 1D
Oct 19, 12:14:10 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285.27K
Avg. vol.
839.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
13.69
Shares outstanding
57.07M
Mkt. cap
285.27K
Avg. vol.
839.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
13.69
Shares outstanding
57.07M
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.77K
2.06K
2.95K
1.58K
Operating expense
34.77K
2.06K
2.95K
1.58K
Total operating expenses
34.77K
2.06K
2.95K
1.58K
Operating income
-34.77K
-2.06K
-2.95K
-1.58K
Other non operating income
-2.27K
-1.16K
-10.54K
-1.91K
EBT including unusual items
-39.64K
-5.83K
-16.55K
-6.82K
EBT excluding unusual items
-39.64K
-5.83K
-16.55K
-6.82K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.64K
-5.83K
-16.55K
-6.82K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.61K
-2.61K
-3.06K
-3.33K
Net interest expenses
-2.61K
-2.61K
-3.06K
-3.33K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.38K
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps